Pluristem Therapeutics

Industry

Life Sciences

Year Founded

Website

Ownership

Public

Exchange / Symbol

Pluristem’s cell therapies advance the field of regenerative medicine, with potentially groundbreaking applications for treating damaged muscle, hematology deficiencies, and inflammation. Pluristem sources its therapeutic cells from the placenta, an ethically accepted and potent source.

Public Since

Chief Executive Officer

Chairman of the Board

Chief Financial Officer

Insider Ownership

Key Investors

Employee Count

Trailing Revenues

Trailing Operating Profits

Trailing Net Income

Auditors

Investment Bankers

Law Firm

Corporate Mission

Proudest Accomplishment

Next Milestone

Geographic Markets Served

Growth Drivers

Growth Headwinds

Indicia of Customer Satisfaction

Scalability

Workforce

Focus of Recruitment

Research and Development

Patent Count

Economic Sensitivity

Unique Metrics

Greatest Concern

Company Press Releases

SEC Filings

Reports

Podcasts

Chatboard

Yahoo Finance

Yahoo Finance